Timeline of lab leaks
Jump to navigation
Jump to search
This is a timeline of lab leaks, documenting notable laboratory-acquired infections, confirmed and suspected laboratory leaks, biosafety failures, research controversies, and policy responses related to the handling of dangerous pathogens. It spans from the early twentieth century to the present and includes both well-documented incidents and debated hypotheses. The timeline aims to provide historical context on how laboratory risks have evolved, how biosafety standards have emerged, and how scientific, governmental, and international institutions respond to accidents, controversies, and ongoing uncertainties in high-risk biological research.
Sample questions
The following are some interesting questions that can be answered by reading this timeline:
Big picture
| Time period | Development summary | More details |
|---|
Full timeline
| Year (Month and date) | Event type | Details | Country (location) |
|---|---|---|---|
| 1900s | Laboratory-acquired infection | Early plague research leads to laboratory infections among scientists studying *Yersinia pestis*, underscoring the dangers of aerosol exposure before modern containment standards. | India; France |
| 1918–1920 | Laboratory research controversy | Influenza virus samples from the 1918 pandemic are later preserved and studied under laboratory conditions, raising long-term biosafety concerns regarding pathogen retention. | Global |
| 2026 | Biosafety governance initiative | International experts propose a global incident-reporting registry for laboratory accidents involving high-risk pathogens to improve transparency and learning across borders. | Global |
| 2026 | Laboratory automation risk assessment | Scientific bodies assess biosafety implications of increasingly autonomous laboratory systems, including robotic handling and closed-loop experimentation. | Global |
| 2027 | Policy guidance update | The World Health Organization updates guidance on biosafety levels and risk assessment for novel and synthetic pathogens. | Global |
| 2027 | Laboratory training reform | Major research funders require standardized, recurring biosafety certification for personnel working in BSL-3 and BSL-4 laboratories. | Global |
| 1928 | Laboratory-acquired infection | Researchers working with yellow fever virus contract infections during early vaccine and vector research, highlighting risks prior to modern containment. | Brazil; United States |
| 2028 | Oversight expansion | National regulators expand inspection authority and unannounced audits for high-containment laboratories following reviews of prior safety lapses. | United States; European Union |
| 2028 | Dual-use research framework | International scientific organizations refine criteria for identifying and mitigating dual-use research of concern in life sciences. | Global |
| 2029 | Incident response coordination | Multinational exercises simulate cross-border responses to hypothetical laboratory releases to test notification and containment protocols. | Global |
| 2030 | Long-term biosafety review | Governments and scientific bodies conduct comprehensive reviews of a century of laboratory incidents to reassess acceptable risk in pathogen research. | Global |
| 1930 | Laboratory-acquired infection | Psittacosis outbreaks affect laboratory and animal-handling staff studying avian pathogens, contributing to recognition of airborne transmission risks. | United States; Europe |
| 1930s | Laboratory-acquired infections | Early bacteriology laboratories report frequent infections among researchers working with tuberculosis, plague, and brucellosis, illustrating the absence of standardized containment practices. | Global |
| 1936 | Laboratory-acquired infection | Q fever infections occur among laboratory workers handling *Coxiella burnetii*, contributing to recognition of extreme infectivity via aerosols. | Australia; United States |
| 1941 | Laboratory accident | Accidental infections occur among personnel handling *Coccidioides* spp., leading to early recommendations for respiratory protection in mycology labs. | United States |
| 1940s | Early laboratory accident | Researchers working with Brucella and other zoonotic pathogens experience frequent laboratory-acquired infections, helping establish the modern concept of laboratory biosafety and containment. | United States; United Kingdom |
| 1943 | Laboratory accident | U.S. biological research programs experience accidental infections among staff working with anthrax and brucellosis during wartime research expansion. | United States |
| 1949 | Laboratory safety incident | A release of radioactive materials from a U.S. government experiment exposes gaps in laboratory containment and monitoring, influencing later biosafety and biosecurity frameworks. | United States |
| 1950s | Laboratory-acquired infections | Multiple cases of smallpox, tularemia, and Q fever occur among laboratory workers, highlighting the risks of inadequate containment in early microbiology research. | Global |
| 1951 | Laboratory-acquired infection | Multiple tularemia infections occur among laboratory personnel, reinforcing the need for respirators and controlled airflow in microbiology labs. | United States |
| 1952 | Laboratory-acquired infection | Laboratory workers contract hepatitis during blood and serum research, contributing to later adoption of universal precautions in clinical laboratories. | United States |
| 1954 | Laboratory-acquired infection | Researchers studying Venezuelan equine encephalitis experience laboratory infections, contributing to recognition of aerosol transmission risks in laboratories. | United States |
| 1957 | Laboratory biosafety incident | Influenza research laboratories report accidental exposures during vaccine strain development, highlighting risks in large-scale viral culture. | Global |
| 1959 | Laboratory-acquired infection | Poliovirus infections among laboratory workers prompt tighter controls during vaccine research and production. | Global |
| 1962 | Laboratory containment concern | Concerns emerge over accidental release risks during large-scale poliovirus production for oral polio vaccines. | Global |
| 1963 | Laboratory-acquired infection | Smallpox infections occur among laboratory personnel handling viral samples, reinforcing the need for higher containment levels for orthopoxviruses. | United Kingdom |
| 1964 | Laboratory safety incident | Accidental laboratory infections with rabies virus occur during reminder-vaccine research, highlighting risks associated with neurotropic pathogens. | United States |
| 1965 | Laboratory safety incident | Accidental exposure to Venezuelan equine encephalitis virus occurs during aerosol studies, reinforcing the need for negative-pressure facilities. | United States |
| 1967 (March) | Confirmed lab leak | Smallpox virus escapes from a laboratory at the Marburg Medical Mission Hospital, infecting a laboratory worker and resulting in secondary cases. | Germany (Marburg) |
| 1967 (August) | Confirmed lab accident | The Marburg virus outbreak originates from laboratory work with infected African green monkeys imported for research, causing severe hemorrhagic fever among laboratory staff. | Germany; Yugoslavia (Belgrade) |
| 1968 | Laboratory-acquired infection | Lassa fever virus infects laboratory workers during diagnostic and research activities, emphasizing the need for maximum-containment facilities. | Nigeria; United States |
| 1969 | Policy milestone | The United States renounces offensive biological weapons research, partly motivated by risks associated with laboratory handling of dangerous pathogens. | United States |
| 1971 (March) | Laboratory-associated outbreak | A smallpox outbreak in London is linked to laboratory handling of variola virus, reinforcing concerns about urban laboratory siting. | United Kingdom (London) |
| 1971 | Laboratory safety reform milestone | The U.S. National Cancer Institute suspends several viral oncology programs following biosafety concerns related to tumor virus research. | United States |
| 1972 | Biosafety policy milestone | The Biological Weapons Convention enters into force, restricting biological weapons development and indirectly shaping laboratory biosecurity norms. | Global |
| 1975 | Laboratory safety failure | A laboratory-associated smallpox outbreak in India is linked to research handling variola virus prior to global eradication efforts. | India |
| 1976 | Laboratory-linked outbreak investigation | The Legionnaires’ disease outbreak leads to scrutiny of laboratory handling of *Legionella* cultures during early investigations. | United States (Philadelphia) |
| 1977 | Alleged lab-origin outbreak | The re-emergence of H1N1 influenza closely resembles strains circulating in the 1950s, leading many virologists to conclude that it likely results from a laboratory accident or improper vaccine trial rather than natural evolution. | Global (origin disputed) |
| 1978 (April) | Confirmed lab leak | Smallpox virus escapes from the University of Birmingham Medical School, infecting photographer Janet Parker, who later dies; the incident leads to major reforms in laboratory biosafety. | United Kingdom (Birmingham) |
| 1979 (April) | Suspected lab leak | An anthrax outbreak in Sverdlovsk is later attributed to an accidental release from a military microbiology facility, a conclusion officially acknowledged by Russian authorities in 1992. | Soviet Union (Sverdlovsk; now Yekaterinburg, Russia) |
| 1980 | Biosafety milestone | Following global eradication of smallpox, remaining variola virus stocks are restricted to two high-security laboratories to reduce accidental release risk. | United States; Soviet Union |
| 1981 | Laboratory biosafety reform | The emergence of HIV heightens awareness of laboratory exposure risks and leads to strengthened universal precautions in clinical and research settings. | Global |
| 1983 | Laboratory-acquired infection | Rift Valley fever virus infects laboratory staff during diagnostic work, prompting upgrades to animal and vector containment. | Kenya; United States |
| 1984 | Laboratory safety incident | A laboratory worker contracts Rift Valley fever virus during research, prompting reviews of mosquito-borne pathogen containment. | United States |
| 1988 | Laboratory containment incident | A laboratory worker is exposed to Machupo virus during research activities, underscoring risks associated with arenavirus research. | United States |
| 1989 (November) | Suspected lab-origin outbreak | The Reston ebolavirus emerges in a primate quarantine facility, raising concerns about laboratory and animal-research-related transmission, though no human disease develops. | United States (Virginia) |
| 1990 | Laboratory-acquired infection | Laboratory exposure to Crimean–Congo hemorrhagic fever virus leads to infections among medical and research personnel. | Pakistan; South Africa |
| 1991 | Laboratory exposure | Accidental exposure to hantavirus occurs during rodent research, illustrating zoonotic risks in laboratory animal facilities. | United States |
| 1992 | Official acknowledgment | Russian authorities acknowledge that the 1979 Sverdlovsk anthrax outbreak results from a military laboratory accident, influencing international transparency debates. | Russia |
| 1994 | Laboratory-acquired infection | A researcher contracts Sabia virus following laboratory exposure, drawing attention to risks in handling rare hemorrhagic fever viruses. | Brazil |
| 1996 | Laboratory accident | A laboratory worker becomes infected with Ebola virus following a needle-stick injury during animal research, surviving after intensive care. | Russia (Moscow) |
| 1997 | Laboratory exposure | Accidental exposure to *Burkholderia pseudomallei* (melioidosis) occurs in clinical laboratories, highlighting risks from misidentified pathogens. | Australia |
| 1999 | Laboratory safety failure | A laboratory worker dies following exposure to genetically modified adenovirus, intensifying scrutiny of biosafety in gene therapy research. | United States (Pennsylvania) |
| 2001 | Laboratory safety review | Reviews of biodefense laboratories intensify following expanded pathogen research programs, emphasizing inventory control and personnel reliability. | United States |
| 2001 (September) | Suspected lab-linked biocrime | Anthrax spores are mailed to U.S. media and government offices; the FBI later attributes the material to a U.S. biodefense laboratory, though debate persists. | United States |
| 2002 | Biosafety lapse | Improper handling of West Nile virus samples leads to laboratory infections, prompting reviews of biosafety training and protocols. | United States |
| 2003 (December) | Confirmed lab leaks | SARS-CoV leaks from research laboratories in Singapore and Taiwan due to biosafety failures following the original SARS outbreak. | Singapore; Taiwan |
| 2004 (April) | Confirmed lab leak | A SARS laboratory accident at China’s National Institute of Virology in Beijing infects multiple researchers and causes secondary transmission. | China (Beijing) |
| 2004 | Laboratory biosafety review | Global reviews of SARS laboratory incidents lead to strengthened WHO biosafety guidance for coronavirus research. | Global |
| 2005 | Laboratory containment lapse | Influenza virus samples are accidentally distributed to laboratories worldwide during proficiency testing, raising concerns about quality control. | Global |
| 2006 | Laboratory containment failure | Accidental exposure to live tuberculosis bacteria occurs during laboratory work, highlighting ongoing risks in clinical microbiology laboratories. | Canada |
| 2006 | Laboratory-acquired infection | Laboratory workers are infected with vaccinia virus during smallpox vaccine research, prompting updates to vaccination and handling policies. | United States |
| 2007 (August) | Confirmed lab leak | Foot-and-mouth disease virus escapes from the Pirbright laboratory complex, linked to failures in laboratory wastewater containment systems. | United Kingdom (Surrey) |
| 2008 | Laboratory-acquired infection | Brucellosis infections are reported among laboratory workers due to improper handling of bacterial cultures. | Spain |
| 2009 | Biosafety concern | Laboratories handling pandemic H1N1 influenza rapidly scale up work, raising concerns about containment capacity and personnel training under emergency conditions. | Global |
| 2010 | Laboratory-acquired infection | Q fever infections among laboratory workers trigger revisions to handling protocols for highly infectious intracellular bacteria. | Netherlands |
| 2011 | Research controversy | Experiments modifying H5N1 influenza to enhance transmissibility in mammals spark global debate over laboratory risk and dual-use research of concern. | Netherlands; United States |
| 2011 | Laboratory infection | A researcher in Taiwan becomes infected with SARS-CoV during laboratory work, leading to temporary suspension and investigation of facilities. | Taiwan |
| 2012 | Biosafety controversy | Gain-of-function experiments on H5N1 avian influenza prompt global debate over laboratory risk and lead to a temporary research moratorium. | Netherlands; United States |
| 2013 | Laboratory oversight issue | High-containment laboratories expand globally, prompting debate over whether increased numbers of BSL-3 and BSL-4 facilities elevate accident risks. | Global |
| 2014 (June–July) | Confirmed lab safety failures | The U.S. CDC reports multiple biosafety incidents, including accidental exposure of workers to live anthrax and improper shipment of live avian influenza virus. | United States (multiple locations) |
| 2014 (July) | Discovery of lab containment failure | Forgotten vials of viable smallpox virus are discovered in an FDA laboratory storage room, prompting renewed scrutiny of pathogen storage practices. | United States (Bethesda, Maryland) |
| 2014 | Laboratory safety stand-down | U.S. federal laboratories temporarily halt work with select agents to review biosafety practices after multiple reported incidents. | United States |
| 2015 | Biosafety policy response | The U.S. government pauses federal funding for certain gain-of-function research involving influenza, SARS, and MERS viruses due to laboratory risk concerns. | United States |
| 2015 | Laboratory-acquired infection | Laboratory exposure leads to brucellosis cases among researchers, reinforcing the need for biosafety cabinets and respiratory protection. | United States |
| 2015 | Laboratory oversight incident | A biosafety lapse involving live *Bacillus anthracis* samples prompts temporary shutdowns and retraining at U.S. federal laboratories. | United States |
| 2016 | Laboratory safety incident | A laboratory worker is potentially exposed to Zika virus during research, prompting internal reviews of vector-borne pathogen handling. | United States |
| 2016 | Pathogen reconstruction debate | Scientists successfully reconstruct horsepox virus in a laboratory, renewing concerns about the ease of recreating eradicated or extinct pathogens. | Canada |
| 2017 | Regulatory action | International scientific bodies emphasize stricter oversight of dual-use life sciences research following repeated laboratory safety incidents. | Global |
| 2018 | Biosafety warning | U.S. diplomatic cables express concern about safety practices at the Wuhan Institute of Virology during visits by embassy officials. | China (Wuhan) |
| 2018 | Laboratory compliance action | A major U.S. biodefense laboratory loses access to select agents following repeated safety violations, underscoring enforcement of biosafety regulations. | United States (Fort Detrick, Maryland) |
| 2019 | Biosafety governance concern | Calls intensify for international transparency and incident reporting standards for high-risk pathogen laboratories. | Global |
| 2019 | Industrial laboratory accident | An accidental release of *Brucella* bacteria from a pharmaceutical facility results in thousands of infections, drawing attention to biosafety beyond research laboratories. | China (Lanzhou) |
| 2019 (November–December) | Disputed origin hypothesis | The origin of the COVID-19 pandemic becomes the subject of global debate, with one hypothesis proposing accidental release from a research laboratory in Wuhan; no definitive conclusion is reached. | China (Wuhan) |
| 2020 | Laboratory safety scrutiny | Global attention intensifies on biosafety standards, laboratory transparency, and pathogen research governance following the COVID-19 pandemic. | Global |
| 2021 (May) | Official investigation milestone | The U.S. government directs intelligence agencies to assess the likelihood of a laboratory accident versus natural spillover as the origin of SARS-CoV-2. | United States |
| 2020 | Laboratory operations adjustment | Many high-containment laboratories reduce or suspend non-essential work during the COVID-19 pandemic to minimize accident risk under strained conditions. | Global |
| 2021 | Biosafety reporting initiative | International discussions advance proposals for standardized, transparent reporting of laboratory accidents involving high-risk pathogens. | Global |
| 2022 | Policy reassessment | The World Health Organization calls for stronger international frameworks governing high-risk pathogen research and laboratory safety. | Global |
| 2022 | Biosafety audit expansion | Governments increase audits and reporting requirements for laboratories handling select agents following pandemic-era reviews. | United States; European Union |
| 2023 | Laboratory workforce concern | Reports highlight fatigue, staffing shortages, and training gaps as emerging risk factors for laboratory accidents. | Global |
| 2023 | Ongoing reassessments | Multiple intelligence agencies and scientific bodies maintain differing assessments regarding the plausibility of a COVID-19 lab-leak scenario, reflecting continued uncertainty. | Global |
| 2024 | Governance debate | Policymakers and scientists debate limits on gain-of-function and pathogen-enhancement research amid expanding global high-containment capacity. | Global |
| 2024 | Ongoing biosafety debate | Advances in synthetic biology and pathogen reconstruction renew concerns about accidental release risks from high-containment laboratories. | Global |
| 2025 | Ongoing biosafety challenge | The rapid adoption of AI-assisted biology and automated laboratories raises new questions about oversight, error propagation, and accidental release risks. | Global |
Meta information on the timeline
How the timeline was built
The initial version of the timeline was written by FIXME.
Funding information for this timeline is available.
Feedback and comments
Feedback for the timeline can be provided at the following places:
- FIXME
What the timeline is still missing
- https://www.openmindmag.org/articles/the-murky-history-of-lab-leaks
- https://reporter.rit.edu/features/lab-leaks-history
- https://www.independentsciencenews.org/health/the-long-history-of-accidental-laboratory-releases-of-potential-pandemic-pathogens/
- https://www.phe.gov/s3/BioriskManagement/biosecurity/Pages/History.aspx